Consistently, the data here suggest that histone acetylating conditions, such as upon SAHA application, improve colitis by a mechanism involving the local upregulation of EBI3 and formation of the anti-inflammatory cytokine IL-35 in colon epithelium. This evidence concerns the gene EBI3 and colitis.